The Canakinumab Biosimilar Anti-IL1B Antibody is a cutting-edge product developed for researchers studying the role of interleukin-1 beta (IL-1B) in inflammatory responses. This antibody, which is produced through a biosimilar process, specifically targets and neutralizes IL-1B, a key pro-inflammatory cytokine involved in various inflammatory conditions.The Canakinumab Biosimilar Anti-IL1B Antibody has been extensively validated for its specificity and efficacy in blocking IL-1B activity in both in vitro and in vivo experiments. Researchers can use this antibody in a wide range of applications, including ELISA, western blotting, and immunohistochemistry, to study the effects of IL-1B inhibition on immune responses.
By targeting IL-1B, this antibody offers a unique opportunity to explore potential therapeutic strategies for a variety of inflammatory diseases, such as rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease. Its role in modulating the inflammatory cascade makes it a valuable tool for researchers seeking to better understand the mechanisms underlying these conditions and develop novel treatment options.
Product Name:
Canakinumab (Anti-IL1B) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0101
Target:
IL1B
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
ACZ885
Description:
Anti-IL1B(canakinumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
